Fracture of the odontoid process complicating tardive dystonia

Movement Disorders

Volumn 19, Issue 8, 2004, Pages 983-

  Konrad, Carsten ^a   Vollmer Haase, Juliane ^a   Gaubitz, Markus ^a   Nabavi, Dariun G ^a   Reilmann, Ralf ^a   Knecht, Stefan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Complications; Dystonia; Osteoporosis; Rheumatoid arthritis; Spinal lesions

Indexed keywords

ALENDRONIC ACID; BOTULINUM TOXIN A; CALCIUM; FLUPENTIXOL; FLUSPIRILENE; METHOTREXATE; NEUROLEPTIC AGENT; PARATHYROID HORMONE[1-34]; PREDNISONE; RALOXIFENE; RISEDRONIC ACID; TIAPRIDE; TRIHEXYPHENIDYL; VITAMIN D;

ADULT; ANXIETY DISORDER; ARTICLE; BONE TRANSPLANTATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; FEMALE; FRACTURE FIXATION; HUMAN; MAJOR DEPRESSION; NEUROSURGERY; ODONTOID PROCESS FRACTURE; OSTEOPOROSIS; OSTEOSYNTHESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPINE RADIOGRAPHY; TARDIVE DYSKINESIA;

ANTI-DYSKINESIA AGENTS; BONE TRANSPLANTATION; BOTULINUM TOXINS; DYSTONIC DISORDERS; FEMALE; HUMANS; MIDDLE AGED; ODONTOID PROCESS; OSTEOPOROSIS; SPINAL FRACTURES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 19244366444     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20122     Document Type: Article

References (19)

1. Claypool DW, Duane DD, Ilstrup DM, Melton LJ, III. Epidemiology and outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota. Mov Disord 1995;10:608-614.
2. The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol 2000;247:787-792.
3. Chawda SJ, Munchau A, Johnson D, et al. Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation. J Neurol Neurosurg Psychiatry 2000;68: 465-471.
4. Jankovic J, Leder S, Warner D, Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991;41:1088-1091.
5. Angelini L, Broggi G, Nardocci N, Savoiardo M. Subacute cervical myelopathy in a child with cerebral palsy. Secondary to torsion dystonia? Childs Brain 1982;9:354-357.
6. Henry MJ, Pasco JA, Nicholson GC, Seeman E, Kotowicz MA. Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study. J Clin Densitom 2000;3:261-268.
7. Amling M, Posl M, Wening VJ, Ritzel H, Hahn M, Delling G. Structural heterogeneity within the axis: the main cause in the etiology of dens fractures. A histomorphometric analysis of 37 normal and osteoporotic autopsy cases. J Neurosurg 1995;83:330-335.
8. Aggarwal A, Kulshreshtha A, Chaturvedi V, Misra R. Cervical spine involvement in rheumatoid arthritis: prevalence and relationship with overall disease severity. J Assoc Physicians India 1996; 44:468-471.
9. Toyama Y, Hirabayashi K, Fujimura Y, Satomi K. Spontaneous fracture of the odontoid process in rheumatoid arthritis. Spine 1992; 17(Suppl.):S436 -S441.
10. Konrad C, Vollmer-Haase J, Anneken K. Knecht S. Orthopedic and neurological complications of cervical dystonia - review of the literature. Acta Neurol Scand 2004 (in press).
11. Fractures and dislocation of the spine. In: Dee R, Hurst LC, Gruber MA, Kottmeier SA, editors. Principles of orthopaededic practice. New York: McGraw-Hill; 1997. p 1259-1263.
12. Blauth M, Lange UF, Knop C, Bastian L. Vertebral fracture and treatment in elderly. Orthopade 2000;29:302-317.
13. Grob D. Surgical interventions in the cervical spine: where and how? In: Baumgartner H, Dvorak J, Grob D, Munzinger U, Simmen BR, editors. Rheumatoid arthritis. Stuttgart: Thieme: 1995. p 150-156.
14. Adler CH, Zimmerman RS, Lyons MK, Simeone F, Brin MF Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease. Mov Disord 1996;11:79-81.
15. Iwamuro H, Takahashi H, Ide K, Nakauchi J, Taniguchi M. Perioperative treatment with botulinum A toxin prior to posterior cervical decompression in a case with cervical spondylosis caused by spasmodic torticollis secondary to cerebral palsy. No Shinkei Geka 2003;31:1015-1020.
16. Racette BA, Lauryssen C, Perlmutter JS. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases. J Neurosurg 1998;88:328-330.
17. Traynelis VC, Ryken T, Rodnitzky RL, Menezes AH. Botulinum toxin enhancement of postoperative immobilization in patients with cervical dystonia. Technical note. J Neurosurg 1992;77:808-809.
18. Vidal-Marcos A, Sanz-Garcia M, Infante-Crespo B, Ruiz-Castro M, Rustarazo-Perez MT, Palma-Gamiz MA. Botulinum toxin: clinical use and anesthetic implications. Rev Esp Anestesiol Reanim 1996;43:208-211.
19. Delmas PD. Treatment of postmenopausal osteoporosis. Lancet 2002;359:2018-2026.